- Home
- NBTX vs OPK Comparison
NBTX vs OPK Comparison
Compare NBTX & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NBTX | OPK |
|---|---|---|
| Founded | 2003 | 2006 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 921.2M |
| IPO Year | 2018 | 2011 |
Fundamental Metrics
Financial Performance| Metric | NBTX | OPK |
|---|---|---|
| Price | $31.04 | $1.15 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $36.00 | $2.03 |
| AVG Volume (30 Days) | 48.5K | ★ 2.4M |
| Earning Date | 03-31-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $606,879,000.00 |
| Revenue This Year | $60.67 | N/A |
| Revenue Next Year | N/A | $4.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.99 | $1.10 |
| 52 Week High | $41.89 | $1.60 |
Technical Indicators
Market Signals| Indicator | NBTX | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 50.89 | 45.32 |
| Support Level | $20.11 | $1.12 |
| Resistance Level | $41.89 | $1.27 |
| Average True Range (ATR) | 1.72 | 0.04 |
| MACD | -0.29 | -0.00 |
| Stochastic Oscillator | 41.82 | 36.00 |
Price Performance
Historical ComparisonAbout NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.